Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20544 | 456 | 31.0 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
416 | 3 | NEUROENDOCRINE TUMORS//CARCINOID//SMALL CELL CARCINOMA | 28897 |
808 | 2 | RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//ANTIBODY DRUG CONJUGATE | 12023 |
20544 | 1 | MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//ALPHA MELANOCYTE STIMULATING HORMONE HYBRID PEPTIDE | 456 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MELANOMA IMAGING | authKW | 1246526 | 5% | 85% | 22 |
2 | IMAGERIE MOL THER IE VECTORISEE | address | 306108 | 2% | 57% | 8 |
3 | ALPHA MELANOCYTE STIMULATING HORMONE HYBRID PEPTIDE | authKW | 267850 | 1% | 100% | 4 |
4 | MELANOCORTIN TYPE 1 RECEPTOR | authKW | 267850 | 1% | 100% | 4 |
5 | MELANOMA IMAGING AGENT | authKW | 267850 | 1% | 100% | 4 |
6 | MELANOMA TARGETING | authKW | 267850 | 1% | 100% | 4 |
7 | RADIOIODINATED BENZAMIDES | authKW | 267850 | 1% | 100% | 4 |
8 | IMTV | address | 219145 | 1% | 55% | 6 |
9 | ALPHA MELANOCYTE STIMULATING HORMONE PEPTIDE | authKW | 200888 | 1% | 100% | 3 |
10 | TARGETED MELANOMA THERAPY | authKW | 200888 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 1678 | 24% | 0% | 110 |
2 | Chemistry, Medicinal | 1216 | 16% | 0% | 72 |
3 | Chemistry, Organic | 387 | 14% | 0% | 66 |
4 | Oncology | 295 | 15% | 0% | 68 |
5 | Dermatology | 274 | 6% | 0% | 29 |
6 | Biochemical Research Methods | 273 | 9% | 0% | 41 |
7 | Biochemistry & Molecular Biology | 167 | 20% | 0% | 90 |
8 | Medicine, Research & Experimental | 152 | 8% | 0% | 36 |
9 | Chemistry, Multidisciplinary | 47 | 10% | 0% | 44 |
10 | Cell Biology | 46 | 7% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMAGERIE MOL THER IE VECTORISEE | 306108 | 2% | 57% | 8 |
2 | IMTV | 219145 | 1% | 55% | 6 |
3 | U990 | 194790 | 2% | 36% | 8 |
4 | UMR 990 | 179339 | 3% | 18% | 15 |
5 | EA 4231 | 141795 | 1% | 35% | 6 |
6 | CYCLOPHARMA S | 133925 | 0% | 100% | 2 |
7 | U484 | 108791 | 3% | 13% | 13 |
8 | U 990 | 89282 | 0% | 67% | 2 |
9 | UMR INSERM 990 | 89282 | 0% | 67% | 2 |
10 | UMR SEESIB 6504 | 89282 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEAR MEDICINE AND BIOLOGY | 15296 | 6% | 1% | 29 |
2 | JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH | 9051 | 1% | 2% | 6 |
3 | JOURNAL OF NUCLEAR MEDICINE | 6732 | 7% | 0% | 32 |
4 | BIOCONJUGATE CHEMISTRY | 6483 | 5% | 0% | 22 |
5 | MELANOMA RESEARCH | 5474 | 3% | 1% | 12 |
6 | JOURNAL OF RECEPTOR RESEARCH | 4137 | 1% | 1% | 6 |
7 | ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE | 3761 | 1% | 2% | 3 |
8 | PIGMENT CELL RESEARCH | 3044 | 2% | 1% | 7 |
9 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2964 | 3% | 0% | 12 |
10 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2238 | 2% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GUO, HX , GALLAZZI, F , MIAO, YB , (2013) DESIGN AND EVALUATION OF NEW TC-99M-LABELED LACTAM BRIDGE-CYCLIZED ALPHA-MSH PEPTIDES FOR MELANOMA IMAGING.MOLECULAR PHARMACEUTICS. VOL. 10. ISSUE 4. P. 1400-1408 | 29 | 88% | 5 |
2 | GUO, HX , MIAO, YB , (2013) MELANOMA TARGETING PROPERTY OF A LU-177-LABELED LACTAM BRIDGE-CYCLIZED ALPHA-MSH PEPTIDE.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 23. ISSUE 8. P. 2319 -2323 | 27 | 93% | 1 |
3 | GUO, HX , GALLAZZI, F , MIAO, YB , (2012) GALLIUM-67-LABELED LACTAM BRIDGE-CYCLIZED ALPHA-MSH PEPTIDES WITH ENHANCED MELANOMA UPTAKE AND REDUCED RENAL UPTAKE.BIOCONJUGATE CHEMISTRY. VOL. 23. ISSUE 6. P. 1341-1348 | 26 | 87% | 5 |
4 | REN, G , PAN, Y , CHENG, Z , (2010) MOLECULAR PROBES FOR MALIGNANT MELANOMA IMAGING.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 11. ISSUE 6. P. 590-602 | 54 | 43% | 7 |
5 | YANG, JQ , LU, J , MIAO, YB , (2012) STRUCTURAL MODIFICATION ON THE LYS LINKER ENHANCED TUMOR TO KIDNEY UPTAKE RATIOS OF TC-99M-LABELED RGD-CONJUGATED ALPHA-MSH HYBRID PEPTIDES.MOLECULAR PHARMACEUTICS. VOL. 9. ISSUE 5. P. 1418-1424 | 22 | 96% | 2 |
6 | GAO, F , SIHVER, W , JURISCHKA, C , BERGMANN, R , HAASE-KOHN, C , MOSCH, B , STEINBACH, J , CARTA, D , BOLZATI, C , CALDERAN, A , ET AL (2016) RADIOPHARMACOLOGICAL CHARACTERIZATION OF CU-64-LABELED ALPHA-MSH ANALOGS FOR POTENTIAL USE IN IMAGING OF MALIGNANT MELANOMA.AMINO ACIDS. VOL. 48. ISSUE 3. P. 833 -847 | 34 | 57% | 0 |
7 | FLOOK, AM , YANG, JQ , MIAO, YB , (2014) SUBSTITUTION OF THE LYS LINKER WITH THE BETA-ALA LINKER DRAMATICALLY DECREASED THE RENAL UPTAKE OF TC-99M-LABELED ARG-X-ASP-CONJUGATED AND X-ALA-ASP-CONJUGATED ALPHA-MELANOCYTE STIMULATING HORMONE PEPTIDES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 21. P. 9010 -9018 | 20 | 100% | 0 |
8 | EBERLE, AN , BAPST, JP , CALAME, M , TANNER, H , FROIDEVAUX, S , (2010) MSH RADIOPEPTIDES FOR TARGETING MELANOMA METASTASES.MELANOCORTINS: MULTIPLE ACTIONS AND THERAPEUTIC POTENTIAL. VOL. 681. ISSUE . P. 133 -142 | 30 | 70% | 9 |
9 | QUINN, T , ZHANG, X , MIAO, Y , (2010) TARGETED MELANOMA IMAGING AND THERAPY WITH RADIOLABELED ALPHA-MELANOCYTE STIMULATING HORMONE PEPTIDE ANALOGUES.GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. VOL. 145. ISSUE 2. P. 245-258 | 42 | 47% | 14 |
10 | CARTA, D , SALVARESE, N , MORELLATO, N , GAO, F , SIHVER, W , PIETZSCH, HJ , BIONDI, B , RUZZA, P , REFOSCO, F , CARPANESE, D , ET AL (2016) MELANOMA TARGETING WITH [TC-99M(N)(PNP3)]-LABELED ALPHA-MELANOCYTE STIMULATING HORMONE PEPTIDE ANALOGS: EFFECTS OF CYCLIZATION ON THE RADIOPHARMACEUTICAL PROPERTIES.NUCLEAR MEDICINE AND BIOLOGY. VOL. 43. ISSUE 12. P. 788 -801 | 28 | 62% | 0 |
Classes with closest relation at Level 1 |